Quest Diagnostics IncorporatedDGXNYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P31
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-2.99%
Q3 20253.09%
Q2 20252.10%
Q1 20252.15%
Q4 20244.02%
Q3 202410.34%
Q2 2024-6.88%
Q1 20248.46%
Q4 20235.79%
Q3 2023-8.65%
Q2 2023-5.24%
Q1 2023-22.02%
Q4 202221.34%
Q3 20229.95%
Q2 2022-0.71%
Q1 2022-8.41%
Q4 20218.67%
Q3 2021-0.47%
Q2 20215.41%
Q1 2021-8.95%
Q4 202012.88%
Q3 202010.00%
Q2 20203.75%
Q1 2020-0.57%
Q4 2019-3.59%
Q3 20190.00%
Q2 2019-5.73%
Q1 20197.87%
Q4 20180.56%
Q3 20180.85%
Q2 2018-3.31%
Q1 2018-19.87%
Q4 20177.09%
Q3 2017-3.20%
Q2 20170.00%
Q1 20179.25%
Q4 2016-2.20%
Q3 2016-4.88%
Q2 2016-2.71%
Q1 20163.03%